High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: filgrastim|DRUG: CMF regimen|DRUG: cyclophosphamide|DRUG: doxorubicin hydrochloride|DRUG: epirubicin hydrochloride|DRUG: fluorouracil|DRUG: mesna|DRUG: methotrexate|DRUG: tamoxifen citrate|PROCEDURE: peripheral blood stem cell transplantation|RADIATION: low-LET electron therapy|RADIATION: low-LET photon therapy
Sponsor: ETOP IBCSG Partners Foundation